Shares of vaccine producer and Pfizer (NYSE: PFE) partner BioNTech ((NASDAQ: ((((BNTX)))))) tumbled 6% Wednesday after it was reported that the companies’ local vaccine distributor, Chinese pharmaceutical firm Fosun, is suspending distribution of the companies’ vaccine because of “defective bottle lids.” Pfizer stock ended the day roughly where it began it.
As multiple news sites were reporting today, Fosun says it found unspecified defects in the lids that close the bottles of a single batch of the companies’ COVID-19 vaccine, batch number 210102. Out of an abundance of caution, China is not permitting the vaccines to be administered in either Hong Kong or Macao (their destinations) — either from batch number 210102 or from a separate batch with number 210102.
Image source: Getty Images.
It’s worth mentioning that China has already made it easier for foreigners to enter the country if they can show they have been inoculated with COVID-19 vaccines produced in China, i.e., not BioNTech or Pfizer‘s vaccine. Perhaps today’s suspension of vaccinations is part of a Chinese effort to favor its own vaccine over foreign-invented variants. (China has been known to suspend product import rights in the past out of political motives.) Whether that’s what’s happening here, just the allegation of manufacturing defects might be enough to make consumers elsewhere incrementally less inclined to take the BioNTech/Pfizer vaccine, and perhaps prefer Chinese-made vaccines instead.
10 stocks we like better than BioNTech SE
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Fintech Zoom Stock Advisor, has tripled the market.*
David and Tom just revealed what they believe are the ten best stocks for investors to buy right now… and BioNTech SE wasn’t one of them! That’s right — they think these 10 stocks are even better buys.
See the 10 stocks
*Stock Advisor returns as of February 24, 2021
Rich Smith has no position in any of the stocks mentioned. The Fintech Zoom has no position in any of the stocks mentioned. The Fintech Zoom has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.